DCPH - Deciphera Pharmaceuticals GAAP EPS of -$0.55 beats by $0.03 revenue of $35.97M beats by $2.96M November, 03 2022 07:06 AM Deciphera Pharmaceuticals Inc. Deciphera Pharmaceuticals press release ( NASDAQ: DCPH ): Q3 GAAP EPS of -$0.55 beats by $0.03 . Revenue of $35.97M (+54.9% Y/Y) beats by $2.96M . For further details see: Deciphera Pharmaceuticals GAAP EPS of -$0.55 beats by $0.03, revenue of $35.97M beats by $2.96M